Spring Investor Conference Financial Performance 2003

Similar documents
Lehman Conference, April 2003

Spring Investor Conference Werner Wenning CFO and Member of the Board

Investor Conference. London, August 6, First Half 2003 Results

Investor Handout Q Results

Investor Handout Q Results

Stockholders Newsletter

Stockholders Newsletter

Stockholders Newsletter

Stockholders Newsletter

Investor Conference Call

EASTMAN CHEMICAL COMPANY EMN January 26, :30 PM EDT. Table of Contents. TABLE 1 Statements of Earnings 1. TABLE 2 Other Sales Information 2-3

Investor Conference Call Q Results

Q Analyst and Investor Briefing March 3, 2009

Q Analyst and Investor Briefing February 26, 2010

Q Analyst and Investor Briefing April 29, 2009

Q Analyst and Investor Briefing July 31, 2012

of 5 01/08/ :58

Investor Conference Call

News Release. Bayer: sales and EBIT at record levels. Financial and innovation targets for 2011 achieved

Bayer increases sales and earnings in the second quarter

Non-Deal Debt Roadshow

Q Analyst and Investor Briefing October 27, 2009

Information for Stockholders. Interim Report for the First Quarter

CropScience Analyst & Investor Days

Investor Handout. Financials. Strategy R & D

Investor Handout. Financials. Strategy R & D. Investor Handout Spring 2001

Investor Handout 1st Half The Transformation has begun 1st Half 2002 Results

News Release. Bayer: operating performance on track. Financial News Conference on fiscal 2010:

July 23, 2013 Media Contact: Michael Hanretta WILMINGTON, Del Investor Contact:

Spring Investor Conference 2003

Q Analyst and Investor Briefing July 28, 2011

Q Analyst and Investor Briefing October 28, 2010

Investor News. Bayer: strong business momentum continues and portfolio transformation underway. Fiscal 2014:

The New Bayer. more highly focused more flexible more transparent more strategic options more entrepreneurial responsibility

Investor Conference Call

LANXESS FY/Q Financial Summary for Investors and Analysts

January 28, 2014 Media Contact: Patty Seif WILMINGTON, Del Investor Contact:

Value across the cycle

Investor Release. BASF confirms outlook for 2012 despite growing economic risks

Third Quarter Results 2005

LANXESS AG Executing on Strategy and Operations

Bayer Polymers Top League Player In A Changing Market

October 25, 2011 Media Contact: Michael Hanretta WILMINGTON, Del Investor Contact:

Investor Conference Call

Investor News. Another record year for Bayer. Fiscal 2015:

Analyst Conference Call Full Year Ludwigshafen, February 27, 2018

Stockholders Newsletter 2004 Interim Report for the Third Quarter

Stockholders Newsletter

LANXESS Q Financial Summary for Investors and Analysts

DANAHER CORPORATION RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES. Three-Month Period Ending

July 22, 2014 Media Contact: Dan Turner WILMINGTON, Del Investor Contact:

Brooks Automation, Inc. Financial Results Conference Call

AGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) (Unaudited)

Financial Report. Bayer: excellent start to as of March 31,

Kurt Bock, CFO UBS Best of Germany Conference New York, September 17, 2009 Tackling the challenges ahead

Quarterly Statement 1st Quarter 2018

BASF 1 st Quarter 2014 Analyst Conference Call May 2, 2014, 8:30 a.m. (CEST), Mannheim

Price: +4% Volume: +1% FX: 0% Portfolio: +0% Δ Q Q Comments. Jun ,633 m

Third-quarter sales and EBIT bsi down in a difficult economic environment

DANAHER CORPORATION RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES. Three-Month (0.02) (0.02) Pretax gain on sales of investments D,E D (0.

Gratifying sales and earnings increases

Investor Handout. Roadshow California

BASF Analyst Conference Call FY 2015

Price: +5% Volume: +1% FX: -4% Portfolio: +6% Q Q Comments. Net Income >100% 126 m 3 m EPS includes 50% contribution of ARLANXEO

DOWDUPONT INC. (Exact name of registrant as specified in its charter)

Ludwigshafen, February 26, 2016

Wells Fargo Securities Industrial & Construction Conference May 8, 2014 New York

LANXESS Q Financial Summary for Investors and Analysts

Stockholders Newsletter 2004 Interim Report for the Second Quarter of 2004

Stockholders Newsletter. Interim Report for the First Half of 2001

BASF We create chemistry. Dr. Lars Budde, Senior Manager Investor Relations EQUITA European Conference, Milan, November 23, 2017

Investor Handout Q April 2012 I Leverkusen

September 18, 2014 / Marijn Dekkers, CEO

2007 PROFORMA COMBINED FINANCIAL INFORMATION FOR AKZO NOBEL AND ICI PER QUARTER AND PER BUSINESS AREA

Safe Harbour. Investor Handout Spring 2002

Stockholders Newsletter

Working To Create Value. Version Summer 2004 Q2'04. Investor Handout. Performance Objectives Opportunities Strategy Financials

Record quarter for Bayer. Interim Report as of March 31, Dynamic start to 2006

Investor Handout 1st Quarter 2002 Results

October 22, 2013 Media Contact: Patty Seif WILMINGTON, Del Investor Contact:

Stockholders Newsletter

Brooks Automation, Inc. 4 th Quarter Fiscal 2013 Financial Results Conference Call

Three Months Ended Year Ended

Reporting Factsheet. BASF Group. Segments Sales EBIT bef. special items EBIT

Tackling the challenges ahead

July 26, Second Quarter 2018 Earnings Presentation

Fiscal 2018 Fourth Quarter Results. July 26, 2018

Interim Report Second Quarter of 2017

Investor Conference Call

Dow Reports Fourth Quarter Results Record Fourth Quarter Sales and Strong Earnings Second Highest Annual Earnings in Company s History

Quarterly Statement 3rd Quarter 2018 BASF Group increases sales, earnings below prior-year quarter

The Dow Chemical Company ("Dow" or the "Company")

CORNING INCORPORATED AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited; in millions, except per share amounts)

BASF with good quarterly results in the chemicals and crop protection businesses

Safe Harbor and Non-GAAP Measures

Financial Results & Outlook for FY2012

First Quarter 2018 Financial Review and Analysis (preliminary, unaudited)

January 24, 2006 Contact: Clif Webb WILMINGTON, Del

Q Earnings Presentation August 2, 2018

VISTEON CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in Millions, Except Per Share Data) (Unaudited)

Transcription:

Spring Investor Conference Financial Performance 2003 Klaus Kühn, CFO Safe Harbor This presentation contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Financial Highlights 2003 Net special items underlying Non-operating result Pre-tax income (loss) After-tax income (loss) Net income (loss) Earnings per share ( ) Q4 7,121 (2,753) (2,774) 21 (103) (232) (2,985) (1,955) (1,952) 225 983 (2.67) % yoy -4.1 + 22.7-72.9-41.5 2003 28,567 (2,585) 1,382 3,532 (791) (1,994) (1,349) (1,361) 3,244 3.293 (1.86) % yoy -3.6 + 66.9-28.2-20.9 + 5.2-26.1 Reconciliation of Basis (197) Hedging gains 2) (net) + 989 + 36 New definition of special items 1) + 828 Reported 2002 underlying cont. Adjusted 2002 underlying cont. 1) Mainly gains from BCS product disposals 2) In 2003 reallocated from financial result to

2003 Hampered by High Special Charges + 1,382 (1,927) Total Special items (2,585) 2003 before special items Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs (619) + 469 2003 Other special items Portfolio changes 2003 Hampered by High Special Charges + 1,382 2003 before special items Polymers ( 1,134) - 1.927 Chemicals (476) HealthCare (317) Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs Impairment losses and valuation adjustments Polymers: Plastics/Rubber: (463) Summe Polyurethanes/Coatings/Fibers: Sondereinflüsse (671) -2.585 (619) + 469 2003 Other special items Portfolio changes

2003 Hampered by High Special Charges + 1,382 2003 before special items Polymers ( 1,134) - 1.927 Chemicals (476) HealthCare (317) Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs Impairment losses and valuation adjustments Chemicals: Fine Chemicals: (286) Textile Chemicals Summe Paper Chemicals Sondereinflüsse (190) Inorganic Pigments -2.585 (619) + 469 2003 Other special items Portfolio changes 2003 Hampered by High Special Charges + 1,382 2003 before special items Polymers ( 1,134) - 1.927 Chemicals (476) HealthCare (317) Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs Impairment losses and valuation adjustments HealthCare: Summe Plasma Business: Sondereinflüsse (317) -2.585 (619) + 469 2003 Other special items Portfolio changes

2003 Hampered by High Special Charges + 1,382 (1,927) Restructuring and other asset writedowns: Restructuring CropScience: Summe (102) Restructuring Polymers: Sondereinflüsse (135) Closure Kyoto: (119) Write-down SAP System: - 2.585 (100) Others: (52) 2003 before special items Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs (619) + 469 2003 Other special items Portfolio changes 2003 Hampered by High Special Charges + 1,382 (1,927) Summe Other special items: Sondereinflüsse Accounting measures Baycol: (300) - 2.585 Senior part-time working: (209) Others: (110) 2003 before special items Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs (619) + 469 2003 Other special items Portfolio changes

2003 Hampered by High Special Charges + 1,382 (1,927) Total Special items (2,585) 2003 before special items Impairment losses, valuation (508) adjustments Restructuring expenses, other asset write-downs (619) + 469 2003 Other special items Portfolio changes Financial Highlights in Q4 Net special items underlying Non-operating result Pre-tax income (loss) After-tax income (loss) Net income (loss) Earnings per share ( ) 7,428 (340) (281) (59) 761 (300) (640) (418) (412) 829 1,679 (0.56) 7,121 (2,753) (2,774) 21 (103) (232) (2,985) (1,955) (1,952) 225 983 (2.67) yoy -307-2,413 2,493 80-864 68-2,345-1,537-1,540-604 -696-2.11

Components of Q4 Trend Q4'02 Q4'03 % yoy + Acquisitions / Divestitures - Currencies -Prices + Volumes 7,428 (265) (525) (74) 557 7,121-3.6-7.0-1.0 + 7.5-4.1 CropScience (net) Household Ins., CC Polymer Latex, PO Organic Pigm., CH Walothen, CH Others (155) (42) (42) (9) (10) (7) Financial Highlights in Q4 Net special items underlying Non-operating result Pre-tax income (loss) After-tax income (loss) Net income (loss) Earnings per share ( ) 7,428 (340) (281) (59) 761 (300) (640) (418) (412) 829 1,679 (0.56) 7,121 (2,753) (2,774) 21 (103) (232) (2,985) (1,955) (1,952) 225 983 (2.67) yoy -307-2,413 2,493 80-864 68-2,345-1,537-1,540-604 -696-2.11

HealthCare Pharma / Biological Products in LC 1,227 1,214-1.1 8.5 (256) (434) (378) (810) Special Items (364) (785) Underlying (14) (25) (222) (298) 238 (203) HealthCare Consumer Care / Diagnostics in LC 894 893 0.1 9.9 427 135-68.4 333 27-91.9 Special items 239 (47) Underlying 93 74-20.4 397 23-94.2 583 178-69.5

HealthCare Animal Health in LC 212 193-9.0-0.8 48 52 8.3 26 42 61.5 Special Items (11) 20 Underlying 37 22-40.5 42 9-78.6 65 124 90.8 CropScience in LC 1,435 1,411-1.7 6.0 Crop Protection 1,256 1,212-3.6 - Insecticides 389 320-17.7 - Fungicides 302 330 9.3 - Herbicides 549 454-17.3 - Seed Treatment 56 103 83.9 - Others (Transitional ACS) (40) 5 Environmental Science 132 137 3.8 BioScience 47 62 31.9

CropScience 221 153-30.8 (55) (18) Special items 70 41 Underlying (125) 23 295 304 3.1 342 162-52.6 Polymers Plastics / Rubber in LC 1,259 1,183-6.0-0.5 10 (25) (50) (625) Special items (35) 577 Underlying (15) (48) 13 144 126 96-23.8

Polymers PUR / Coatings / Fibers in LC 1,292 1,255-2.9 3.9 211 103-51.2 (145) (687) Special items (194) (737) Underlying 49 50 190 129-32.1 246 280 15.4 Chemicals in LC 872 818-6.2-2.3 136 (1) 7 (552) Special Items 13 (528) Underlying (6) (24) 96 75-21.9 170 124-27.1

Non-Operating Result 2003 2002 2003 % Non-operating result (654) (791) -20.9 Income (exp.) from affiliated companies - net 223 (93) Interest expense - net (449) (353) + 21.4 Interest portion of provisions (296) (281) + 5.1 Exchange losses - net (5) (31) Miscellaneous - net (127) (33) Income (loss) before income-taxes 956 (1,994) Taxes 2003 Income taxes* Germany Other countries Effective tax rate (%) Other taxes 2002 107 (45) 152 (11.2) (221) 2003 645 406 239 (32.3) (303) * including deferred taxes

Balance Sheet Structure 2003 billion 37.4 (10%) 37.4 (10%) Property, Plant, Equipment 9.9 (-20%) 12.2 (-20%) Stockholders equity Intangibles Investments 6.5 (-27%) 1.8 (-19%) 8.9 (+6%) Provisions Trade a/c receiv. + inventories 11.0 (-8%) 4.7 (-1%) Remaining liabilities Other current assets 6.7 (+34%) 9.4 (-7%) Financial obligations Excluding minority interests, deferred taxes and deferred charges/income Free Cash Flow 2003 FY 2002 FY 2003 829 225 3,085 3,244 +/- Changes in working capital = 850 1,679 758 983 1,373 4,458 49 3,293 - Capital expenditures (638) (469) (2,239) (1,653) = Free operating cash flow 1,041 514 2,219 1,640 - Interest, dividends (81) (98) (964) (1,081) = Free cash flow 960 416 1,255 559 +/- Acquisitions / divestments 1,025 280 (4,759) 1,830 = Free cash flow after acquis./divest. 1,985 696 (3,504) 2,389 Changes due to cash payments - Derivatives, currencies, other (1,985) (597) (696) (282) 3,504 (1,180) (2,389) (520) Net debt (balance sheet) (2,582) (978) 2,324 (2,909)

Dividend 2003 Earnings per share - 1.86 Cash flow per share 4.44 1.40 2000 0.90 0.90 0.50 2001 2002 2003